Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
389 participants
OBSERVATIONAL
2020-11-01
2022-03-16
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of a Spherical Hydrophilic Acrylic Intraocular Lens
NCT04998409
Evaluation of an Hydrophilic Acrylic Intraocular Lens
NCT04793789
Visual Outcomes of a Segmental Refractive Multifocal Intraocular Lens
NCT03452969
Safety and Effectiveness of an Hydrophilic Acrylic Intraocular Lens
NCT04789538
Visual Acuity After the Combined Binocular Implantation of +2.75 Diopters and +3.25 Diopters Tecnis Multifocal Intraocular Lenses.
NCT02633072
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients already implanted with study lens
No intervention as patients are already implanted.
trifocal lens
not applicable as patients are already implanted with the trifocal lens
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
trifocal lens
not applicable as patients are already implanted with the trifocal lens
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Patients who had an uncomplicated (no intra-operative complication) aged-related cataract surgery
3. Currently implanted with an the study lens into the capsular bag in at least one eye
4. One-year post surgery follow-up (365 days -14 days/+365 days) for the study eye at the time of the postoperative visit
5. Patient is willing and capable of providing informed consent
6. Patient is willing and capable of complying with visits and procedures as defined by this protocol
Exclusion Criteria
2. Preoperative documented endothelial cell count of less than 2000/mm2 (if available)
3. Any preoperative documented ocular disorder that could potentially cause a clinically significant future visual acuity loss
4. Any preoperative documented clinically significant anterior segment pathology (e.g. chronic uveitis, iritis, aniridia, rubeosis iridis, anterior membrane dystrophies, poor pupil dilation, etc.)
5. Any preoperative documented clinically significant abnormal corneal finding (e.g. keratoconus, pellucid marginal degeneration, or irregular astigmatism, clinically significant corneal membrane dystrophies)
6. Any preoperative documented clinically significant condition that could affect IOL stability (e.g. zonular dialysis, evident zonular weakness or dehiscence, etc.)
7. Any preoperative documented history of clinically significant retinal pathologies or ocular diagnosis (e.g. diabetic retinopathy, ischemic diseases, macular degeneration, retinal detachment, optic neuropathy optic nerve atrophy, amblyopia, strabismus, microphthalmos, aniridia, epiretinal membrane etc.) that could alter or limit final postoperative visual prognosis
8. Any preoperative acute infection (acute ocular disease, external/internal infection, systemic infection)
9. Any previous preoperative intraocular and corneal surgery
10. Preoperative documented uncontrolled glaucoma or IOP higher than 24mmHg under ocular hypertension treatment
11. Preoperative documented or current systemic or ocular pharmacotherapy that effects patients' vision
12. Any other preoperative documented or current pathology or condition that could be a risk for the patient according to the investigator opinion
13. Women during pregnancy and/or lactation at time of enrollment into the study
14. Patients unable to meet the limitations of the protocol or likely of non-cooperation during the trial
15. Patients whose freedom is impaired by administrative or legal order
16. Subject is enrolled in any other concurrent clinical study, with the exception of local mandatory governmental registries and observational studies/registries, that do not affect patients' vision
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Carl Zeiss Meditec AG
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Augencentrum Michelfield
Michelfeld, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
LISA tri 839 BER-401-19
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.